Boston Scientific Corp. (NYSE: BSX): Stifel reiterated a Buy rating with a $58 target price. The consensus target is $60.31, and Monday’s $53.80 close was up almost 6% on the day. Reports indicated the company is likely to win FDA approval for a new method of treating abnormal heartbeats.
Church & Dwight Co. Inc. (NYSE: CHD): Truist Financial upgraded the shares to Buy from Hold. The firm also lifted its $95 target price to $105, above the $99.61 consensus target. The stock closed on Monday at $94.43.
Ciena Corp. (NYSE: CIEN): Needham reiterated a Buy rating but lowered its target price to $50. The consensus target is $56.06, and Monday’s close was at $42.05.
Civitas Resources Inc. (NYSE: CIVI): Jefferies maintained its Buy rating, and its $100 target price is well above the consensus target of $87.86. Monday’s final trade was for $80.27 a share.
CrowdStrike Holdings Inc. (NASDAQ: CRWD): When Morgan Stanley lowered its Overweight rating to Equal Weight, its target price dropped to $167 from $178. The consensus target is $180.93. Monday’s closing share price was $144.03.
Denbury Inc. (NYSE: DEN): Jefferies downgraded the shares from Buy to Hold with a $91 target price. The consensus target is $96.78, and Monday’s close was at $90.28.
Emerson Electric Co. (NYSE: EMR): The Hold rating at Argus has been changed to Buy. The firm’s $110 target price compares with a consensus target of $107.38 and Monday’s close at $98.12.
Energizer Holdings Inc. (NYSE: ENR): Truist Financial cut its Buy rating to Hold and reduced its $40 target price to $35. The $37.50 consensus target also compares to Monday’s closing print of $34.30.
Essex Property Trust Inc. (NYSE: ESS): Though Truist Financial downgraded the stock to Hold from Buy, the analyst raised the $255 price target to $266. The consensus target is $249.11, and the stock closed on Monday at $238.07.
IDEX Corp. (NYSE: IEX): Oppenheimer reiterated an Outperform rating with a $245 target price. The consensus target is $233.41. The final trade on Monday was for $227.01 a share.
Kimco Realty Corp. (NYSE: KIM): Compass Point upgraded the stock to Buy from Neutral and has a $22 price target. The consensus target is $22.72. The stock closed at $18.78 on Monday.
Sponsored: Find a Qualified Financial Advisor
Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to 3 fiduciary financial advisors in your area in 5 minutes. Each advisor has been vetted by SmartAsset and is held to a fiduciary standard to act in your best interests. If you’re ready to be matched with local advisors that can help you achieve your financial goals, get started now.
